FIRST CHOICE MEDICAL CARE — All Prescriptions & Medications — Page 3
Practice Code: Y05080 | HARROW, HA2 9LG
Showing results 101-150 of 333
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Biphasic isophane insulin | 85 | 555 | £2.3K | -23.8% ▼ |
| Fluticasone propionate (Inhalation) | 84 | 111 | £2.4K | -78.3% ▼ |
| Quinine sulfate | 83 | 1,652 | £261 | -71.3% ▼ |
| Alogliptin | 82 | 4,032 | £3.6K | -67.7% ▼ |
| Diclofenac diethyl | 82 | 9,800 | £875 | -76.9% ▼ |
| Felodipine | 80 | 1,596 | £185 | -86.5% ▼ |
| Nitrofurantoin | 78 | 922 | £476 | -83.7% ▼ |
| Olanzapine | 76 | 1,435 | £199 | -79.5% ▼ |
| Clarithromycin | 76 | 1,498 | £315 | -69.0% ▼ |
| Irbesartan | 75 | 3,528 | £123 | -69.2% ▼ |
| Morphine sulfate | 75 | 11.8K | £317 | -88.6% ▼ |
| Betamethasone valerate | 75 | 5,784 | £346 | -80.5% ▼ |
| Levetiracetam | 74 | 2,196 | £141 | -83.8% ▼ |
| Bumetanide | 72 | 1,155 | £120 | -73.6% ▼ |
| Alfacalcidol | 72 | 2,790 | £252 | -41.8% ▼ |
| Doxycycline hyclate | 71 | 715 | £68 | -86.1% ▼ |
| 71 | 74 | £386 | -69.9% ▼ | |
| 71 | 890 | £274 | -66.0% ▼ | |
| Sodium valproate | 70 | 2,670 | £542 | -78.0% ▼ |
| Docusate sodium | 69 | 2,400 | £178 | -81.4% ▼ |
| Pravastatin sodium | 69 | 672 | £37 | -78.8% ▼ |
| Loratadine | 69 | 3,308 | £71 | -67.0% ▼ |
| Fluoxetine hydrochloride | 67 | 2,014 | £52 | -93.4% ▼ |
| Carbamazepine | 66 | 1,539 | £178 | -77.8% ▼ |
| Aripiprazole | 65 | 875 | £135 | -74.5% ▼ |
| Levodopa/carbidopa/entacapone | 65 | 2,548 | £843 | +132.4% ▲ |
| Amantadine hydrochloride | 64 | 896 | £241 | +129.8% ▲ |
| Donepezil hydrochloride | 64 | 448 | £23 | -79.3% ▼ |
| Phenoxymethylpenicillin (Penicillin V) | 64 | 5,648 | £215 | -79.1% ▼ |
| Pioglitazone hydrochloride | 64 | 1,036 | £47 | -27.6% ▼ |
| Mometasone furoate | 62 | 65 | £501 | -84.6% ▼ |
| Etoricoxib | 61 | 700 | £137 | -24.3% ▼ |
| Melatonin | 60 | 4,308 | £1.7K | -82.0% ▼ |
| Hyoscine butylbromide | 58 | 1,582 | £114 | -75.1% ▼ |
| Bendroflumethiazide | 58 | 2,548 | £40 | -92.5% ▼ |
| Ranolazine | 58 | 3,280 | £597 | -65.9% ▼ |
| Edoxaban | 57 | 504 | £844 | -91.9% ▼ |
| Biphasic insulin aspart | 57 | 421 | £2.5K | -43.9% ▼ |
| Venlafaxine | 54 | 840 | £193 | -93.6% ▼ |
| Allopurinol | 54 | 3,080 | £67 | -94.8% ▼ |
| Isosorbide dinitrate | 53 | 742 | £221 | +194.7% ▲ |
| Flupentixol hydrochloride | 53 | 742 | £63 | +61.8% ▲ |
| Calcipotriol | 53 | 7,680 | £3.1K | -68.9% ▼ |
| Semaglutide | 52 | 1,072 | £4.4K | -78.4% ▼ |
| Risedronate sodium | 51 | 272 | £70 | -58.0% ▼ |
| Bicalutamide | 51 | 357 | £23 | +57.6% ▲ |
| Combined ethinylestradiol 30mcg | 49 | 4,010 | £421 | -82.4% ▼ |
| Tiotropium bromide | 48 | 461 | £1.4K | -84.2% ▼ |
| Mometasone furoate | 47 | 3,200 | £319 | -64.8% ▼ |
| Buprenorphine | 45 | 263 | £918 | -87.7% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.